Geode Capital Management’s BioXcel Therapeutics BTAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $51K | Buy |
28,182
+6,120
| +28% | +$11.1K | ﹤0.01% | 4214 |
|
|
2025
Q1 | $44.8K | Buy |
22,062
+2,564
| +13% | +$5.21K | ﹤0.01% | 4219 |
|
|
2024
Q4 | $117K | Buy |
19,498
+870
| +5% | +$5.21K | ﹤0.01% | 4060 |
|
|
2024
Q3 | $182K | Buy |
18,628
+1,958
| +12% | +$19.1K | ﹤0.01% | 3931 |
|
|
2024
Q2 | $341K | Sell |
16,670
-11,950
| -42% | -$245K | ﹤0.01% | 3717 |
|
|
2024
Q1 | $1.29M | Buy |
28,620
+481
| +2% | +$21.7K | ﹤0.01% | 3264 |
|
|
2023
Q4 | $1.33M | Buy |
28,139
+1,694
| +6% | +$80K | ﹤0.01% | 3232 |
|
|
2023
Q3 | $1.07M | Buy |
26,445
+1,154
| +5% | +$46.7K | ﹤0.01% | 3289 |
|
|
2023
Q2 | $2.69M | Buy |
25,291
+1,345
| +6% | +$143K | ﹤0.01% | 3015 |
|
|
2023
Q1 | $7.15M | Buy |
23,946
+509
| +2% | +$152K | ﹤0.01% | 2464 |
|
|
2022
Q4 | $8.05M | Buy |
23,437
+1,216
| +5% | +$418K | ﹤0.01% | 2402 |
|
|
2022
Q3 | $4.2M | Buy |
22,221
+740
| +3% | +$140K | ﹤0.01% | 2762 |
|
|
2022
Q2 | $4.54M | Buy |
21,481
+2,007
| +10% | +$424K | ﹤0.01% | 2750 |
|
|
2022
Q1 | $6.52M | Buy |
19,474
+643
| +3% | +$215K | ﹤0.01% | 2635 |
|
|
2021
Q4 | $6.13M | Buy |
18,831
+266
| +1% | +$86.5K | ﹤0.01% | 2772 |
|
|
2021
Q3 | $9.02M | Buy |
18,565
+1,264
| +7% | +$614K | ﹤0.01% | 2525 |
|
|
2021
Q2 | $8.04M | Buy |
17,301
+1,511
| +10% | +$703K | ﹤0.01% | 2619 |
|
|
2021
Q1 | $10.9M | Buy |
15,790
+1,775
| +13% | +$1.23M | ﹤0.01% | 2300 |
|
|
2020
Q4 | $10.4M | Buy |
14,015
+1,130
| +9% | +$835K | ﹤0.01% | 2155 |
|
|
2020
Q3 | $8.94M | Buy |
12,885
+2,798
| +28% | +$1.94M | ﹤0.01% | 2009 |
|
|
2020
Q2 | $8.55M | Buy |
10,087
+1,613
| +19% | +$1.37M | ﹤0.01% | 2016 |
|
|
2020
Q1 | $3.03M | Buy |
8,474
+3,524
| +71% | +$1.26M | ﹤0.01% | 2436 |
|
|
2019
Q4 | $1.16M | Buy |
4,950
+1,081
| +28% | +$253K | ﹤0.01% | 3228 |
|
|
2019
Q3 | $435K | Buy |
3,869
+91
| +2% | +$10.2K | ﹤0.01% | 3515 |
|
|
2019
Q2 | $662K | Buy |
3,778
+2,194
| +139% | +$384K | ﹤0.01% | 3366 |
|
|
2019
Q1 | $250K | Buy |
+1,584
| New | +$250K | ﹤0.01% | 3669 |
|